Since its founding in 2013, Capstone has been one of the first shared services organizations to utilize its business model to partner with global pharmaceutical and medical device companies to bring innovative healthcare products to market. Capstone leads development, manages regulatory services, and achieves timely approval of healthcare products. With a highly experienced research and development team, they shepherd each product from concept to approval, helping their partners achieve rapid, scalable growth.
Capstone advances the goals of its corporate partners by bringing new healthcare products to market quickly and efficiently, allowing its clients to expand their product development portfolio without increasing their operating expenses. This approach augments R&D efforts already in place by their clients by providing the necessary capital and human resources to usher the designated projects to completion.
To date, Capstone’s unique approach has resulted in regulatory approvals on more than 20 products in the United States, European Union, and Canada.